Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19
E Rice, DB Oakes, C Holland, HC Moore… - Current Opinion in …, 2023 - journals.lww.com
Summary mAbs and maternal vaccines targeting RSV have the potential to reduce
paediatric morbidity, however this new era of RSV prevention will require ongoing research …
paediatric morbidity, however this new era of RSV prevention will require ongoing research …
COVID-19 and influenza coinfection outcomes among hospitalized patients in the United States: a propensity matched analysis of national inpatient sample
This study aims to provide comparative data on clinical features and in-hospital outcomes
among US adults admitted to the hospital with COVID-19 and influenza infection using a …
among US adults admitted to the hospital with COVID-19 and influenza infection using a …
Spatiotemporal variations of “triple-demic” outbreaks of respiratory infections in the United States in the post-COVID-19 era
Background The US confronted a “triple-demic” of influenza, respiratory syncytial virus
(RSV), and COVID-19 in the winter of 2022, leading to increased respiratory infections and a …
(RSV), and COVID-19 in the winter of 2022, leading to increased respiratory infections and a …
Molecular epidemiology and genetic diversity of human respiratory syncytial virus in Sicily during pre-and post-COVID-19 surveillance seasons
Human respiratory syncytial virus (hRSV) is an important pathogen of acute respiratory tract
infection of global significance. In this study, we investigated the molecular epidemiology …
infection of global significance. In this study, we investigated the molecular epidemiology …
An Antimicrobial Polymer Brush Coating to Fabricate High-Performance, Durable, Self-Sterilization, and Recyclable Face Masks
X Luo, C Yin, L Ji, J Feng, P Zhang, X Wang… - Chemistry of …, 2023 - ACS Publications
The ubiquity of airborne germs poses a significant threat to human respiratory health, as
demonstrated by the COVID-19 pandemic, and since the outbreak of COVID-19, masks have …
demonstrated by the COVID-19 pandemic, and since the outbreak of COVID-19, masks have …
Trends in hospitalization and mortality for influenza and other respiratory viruses during the COVID-19 pandemic in the United States
Seasonal epidemics of respiratory viruses, respiratory syncytial virus (RSV), influenza
viruses, parainfluenza viruses (PIVs), and human metapneumovirus (MPV) are associated …
viruses, parainfluenza viruses (PIVs), and human metapneumovirus (MPV) are associated …
Impact of COVID-19 on the changing pattern of human orthopneumovirus (respiratory syncytial virus) infection in Iran
J Yavarian, S Shatizadeh Malekshahi… - BMC Infectious …, 2023 - Springer
Background Human orthopneumovirus (HOPV) or respiratory syncytial virus (RSV) is one of
the important causes of acute respiratory infections (ARIs) during the cold months of the year …
the important causes of acute respiratory infections (ARIs) during the cold months of the year …
Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022–2023 season
N Korsun, I Trifonova, I Madzharova, I Alexiev… - Frontiers in …, 2024 - frontiersin.org
Background Respiratory syncytial virus (RSV) is a common cause of upper and lower
respiratory tract infections. This study aimed to explore the prevalence of respiratory …
respiratory tract infections. This study aimed to explore the prevalence of respiratory …
Respiratory syncytial virus in pediatric patients with severe acute respiratory infections in Senegal: findings from the 2022 sentinel surveillance season
MM Jallow, MM Diagne, SN Sagne, F Tall, JBN Diouf… - Scientific Reports, 2023 - nature.com
In 2022, many regions around the world experienced a severe respiratory syncytial virus
(RSV) epidemic with an earlier-than-usual start and increased numbers of paediatric …
(RSV) epidemic with an earlier-than-usual start and increased numbers of paediatric …
Development and Validation of a High-Performance Liquid Chromatography with Tandem Mass Spectrometry (HPLC-MS/MS) Method for Quantification of Major …
T Komarov, P Karnakova, O Archakova… - Biomedicines, 2023 - mdpi.com
Molnupiravir is an antiviral drug against viral RNA polymerase activity approved by the FDA
for the treatment of COVID-19, which is metabolized to β-D-N4-hydroxycytidine (NHC) in …
for the treatment of COVID-19, which is metabolized to β-D-N4-hydroxycytidine (NHC) in …